世界卫生组织心理干预阶梯式照护方案在移民人群中的有效性:RESPOND随机对照试验结果
在意大利开展平行组随机对照试验,纳入K10评分至少16分的移民成人,比较阶梯式照护方案(心理急救后依次进行压力时做要紧事和问题管理增强版)与常规照护的疗效。第21周时,干预组焦虑抑郁症状改善优于对照组(系数-3.460,SE=1.050,p=0.001),第7周和第14周也观察到差异,未发生严重不良事件。
要点
- 阶梯式照护组第21周焦虑抑郁症状改善优于常规照护组(系数-3.460,SE=1.050,p=0.001)。
- 第7周(系数-3.742,SE=1.008,p<0.001)和第14周(系数-6.381,SE=1.039,p<0.001)也观察到组间差异。
- 干预组在全部时间点的抑郁和焦虑分别评估、第14和21周创伤后应激障碍症状、全部时间点自评问题功能幸福感均改善更优,无严重不良事件。
核心结论
- 研究提供证据支持对心理困扰升高的移民人群采用阶梯式照护方式提供压力时做要紧事和问题管理增强版。
- 作者认为这些干预低强度、跨诊断且采用任务转移,具有高度可扩展性,现有循证指南和实施工具包应据此更新。
研究设计与样本
- 在意大利开展平行组随机对照试验,招募年龄≥18岁、K10评分至少16分的移民成人。
- 干预组接受心理急救和阶梯式照护方案(压力时做要紧事,以及压力时做要紧事后仍有显著心理困扰者接受问题管理增强版),每种干预持续5-6周,由非专业促进者远程提供。
- 对照组接受心理急救和常规照护。
- 2021年12月14日至2023年4月18日期间,108名移民被随机分配到阶梯式照护干预组,109名被分配到常规照护组。
- 主要结局为随机化后第21周患者健康问卷焦虑抑郁量表(PHQ-ADS)测量的抑郁和焦虑症状自基线变化。
主要发现
- 第21周时,阶梯式照护组焦虑抑郁症状减少优于常规照护组(系数-3.460,SE=1.050,p=0.001)。
- 第7周(系数-3.742,SE=1.008,p<0.001)和第14周(系数-6.381,SE=1.039,p<0.001)也观察到相同差异。
- 阶梯式照护方案还与全部时间点抑郁和焦虑症状分别评估的更大改善、第14和21周创伤后应激障碍症状的更大改善、以及全部时间点自评问题、功能和幸福感的更大改善相关。
- 未发生严重不良事件。
关键数值与推荐
- 纳入标准为移民成人年龄≥18岁且K10评分至少16分。
- 主要结局为随机化后第21周PHQ-ADS测量的抑郁和焦虑症状自基线变化。
- 阶梯式照护组第21周较常规照护组焦虑抑郁症状改善(系数-3.460,SE=1.050,p=0.001)。
- 阶梯式照护组第7周较常规照护组焦虑抑郁症状改善(系数-3.742,SE=1.008,p<0.001),第14周较常规照护组改善(系数-6.381,SE=1.039,p<0.001)。
临床怎么用
- 作者认为研究证据支持对心理困扰升高的移民人群采用阶梯式照护方式提供压力时做要紧事和问题管理增强版。
- 作者认为这些干预低强度、跨诊断且采用任务转移,具有高度可扩展性。
- 作者建议现有循证指南和实施工具包应据此更新。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Migrant populations - including labour migrants, undocumented migrants, asylum seekers, refugees, internationally displaced persons, and other populations on the move - are exposed to a variety of stressors that affect their mental health. We designed and tested the effectiveness of a stepped-care programme consisting of two scalable psychological interventions developed by the World Health Organization (WHO) and locally adapted for migrant populations. A parallel-group randomized controlled trial was conducted in Italy. We recruited migrant adults (≥18 years) with psychological distress (score of at least 16 on the Kessler Psychological Distress Scale, K10). The experimental arm received psychological first aid (PFA) and a stepped-care programme consisting of two WHO interventions adapted for this population group: first, Doing What Matters in Times of Stress (DWM) and, for participants who still reported significant levels of psychological distress after DWM, Problem Management Plus (PM+). Each intervention lasted 5-6 weeks and was delivered remotely by lay facilitators. The control arm received PFA and care as usual (CAU). The primary outcome was the change in symptoms of depression and anxiety from baseline to week 21 after randomization, measured by the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). Between December 14, 2021 and April 18, 2023, 108 migrants were randomized to the stepped-care intervention and 109 to CAU. Analysis of the primary outcome revealed that participants receiving the stepped-care programme showed a greater reduction in anxiety and depression symptoms compared to those receiving CAU (coefficient: -3.460, standard error, SE: 1.050, p=0.001) at week 21. The same difference was observed at week 7 (coefficient: -3.742, SE=1.008, p<0.001) and week 14 (coefficient: -6.381, SE=1.039, p<0.001). The stepped-care programme was also associated with a greater improvement of depression and anxiety symptoms assessed separately at all timepoints, of post-traumatic stress disorder symptoms at weeks 14 and 21, and of self-assessed problems, function and well-being at all timepoints. No serious adverse events occurred. This study provides evidence supporting the stepped-care delivery of DWM and PM+ for migrant population groups with elevated distress. As these interventions are low-intensity, transdiagnostic and task-shifting, they are highly scalable. Existing evidence-based guidelines and implementation packages should be updated accordingly.
引用
- Purgato M, Tedeschi F, Turrini G, et al. Effectiveness of a stepped-care programme of WHO psychological interventions in a population of migrants: results from the RESPOND randomized controlled trial. World Psychiatry. 2025. PMID: 39810692. doi:10.1002/wps.21281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。